For nucleated cells, GAS2 was nearly 40-fold higher expressed in CML (p<0.01); and for CD34+ cells, GAS2 was about 90-fold higher expressed in CML as well (p<0.01, Figure 1A). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.